在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

Phospho-MYBL2 (S577) Antibody

  • 中文名稱:
    磷酸化-MYBL2 (S577)兔多克隆抗體
  • 貨號:
    CSB-PA010298
  • 規(guī)格:
    ¥1090
  • 其他:

產(chǎn)品詳情

  • Uniprot No.:
  • 基因名:
  • 別名:
    B-Myb antibody; BMyB antibody; MGC15600 antibody; MYB L2 antibody; Myb related protein B antibody; Myb-like protein 2 antibody; Myb-related protein B antibody; MybB antibody; MYBB_HUMAN antibody; MYBL 2 antibody; Mybl2 antibody; v myb avian myeloblastosis viral oncogene homolog like 2 antibody; v myb myeloblastosis viral oncogene homolog (avian) like 2 antibody; v myb myeloblastosis viral oncogene homolog like 2 antibody
  • 宿主:
    Rabbit
  • 反應(yīng)種屬:
    Human,Mouse,Rat
  • 免疫原:
    Synthesized peptide derived from Human B-Myb around the phosphorylation site of S577.
  • 免疫原種屬:
    Homo sapiens (Human)
  • 標(biāo)記方式:
    Non-conjugated
  • 抗體亞型:
    IgG
  • 純化方式:
    The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
  • 濃度:
    It differs from different batches. Please contact us to confirm it.
  • 保存緩沖液:
    Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
  • 產(chǎn)品提供形式:
    Liquid
  • 應(yīng)用范圍:
    WB, IF, ELISA
  • 推薦稀釋比:
    Application Recommended Dilution
    WB 1:500-1:2000
    IF 1:200-1:1000
    ELISA 1:40000
  • Protocols:
  • 儲存條件:
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 貨期:
    Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
  • 用途:
    For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產(chǎn)品評價

靶點詳情

  • 功能:
    Transcription factor involved in the regulation of cell survival, proliferation, and differentiation. Transactivates the expression of the CLU gene.
  • 基因功能參考文獻:
    1. results suggest that B-Myb-A3B contributes to DNA damage and could be targeted by inhibiting EGF receptor. PMID: 28276478
    2. The structure and biochemical analysis provide an understanding of how oncogenic B-Myb is recruited to regulate genes required for cell-cycle progression, and the MMB interface presents a potential therapeutic target to inhibit cancer cell proliferation. PMID: 30224471
    3. B-Myb is an independent prognostic marker and serves as a potential target in the diagnosis and/or treatment of NSCLC, and that B-Myb functions as a tumor-promoting gene by targeting IGFBP3 in NSCLC cells. PMID: 29772705
    4. MYBL2 is a key downstream factor of Akt/FoxM1 signaling to promote progression of human glioma, and could be a new candidate gene for molecular targeting therapy and biomarker for radiotherapy of glioma. PMID: 28784180
    5. These results suggested that overexpression of MYBL2 might serve as a novel prognostic biomarker in pancreatic ductal adenocarcinoma patients PMID: 28559119
    6. A total of 41 differentially expressed genes, such as SOCS3, VAPA, and COL5A2, are speculated to have roles in the pathogenesis of acute myocardial infarction; 2 transcription factors FOXO3 and MYBL2, and 2 miRNAs hsa-miR-21-5p and hsa-miR-30c-5p may be involved in the regulation of the expression of these differentially expressed genes. PMID: 29049183
    7. Results suggested that the oncogenic transcription factor HIF-2alpha stabilized VHL disease suppressor B-Myb, which is also a transcription factor, by physical interaction. Some B-Myb-dependent gene expression was similarly affected by B-Myb or HIF-2alpha knockdown, suggesting that stabilization of B-Myb by HIF-2alpha may play a role in specific gene expressions. PMID: 28394947
    8. The MuvB multiprotein complex, together with B-MYB and FOXM1 (MMB-FOXM1) regulate the expression of mitotic kinesins in breast cancer cells. PMID: 28061449
    9. MYBL2 overexpression promotes Gallbladder Cancer cell proliferation through the regulation of the cell cycle at the S and G2/M phase transitions. Thus, MYBL2 could serve as a potential prognostic and therapeutic biomarker in Gallbladder Cancer patients. PMID: 28427077
    10. Study identified B-Myb as a substrate of the pVHL ubiquitin ligase complex, which targets it for degradation via the ubiquitin-proteasome pathway. It also, provide evidence that the regulation of B-Myb by pVHL plays a critical role in von Hippel-Lindau disease. PMID: 27090638
    11. Data indicate that gene expression alterations in endometrial carcinoma samples with high ATAD2 expression showed upregulation of several cancer-related genes including B-MYB gene. PMID: 26308378
    12. We found that B-Myb upregulated expression of the key epithelial-to-mesenchymal transition regulator snail and that it mediated epithelial-to-mesenchymal transition activation and cell invasion by B-Myb. PMID: 25502082
    13. conclude that downregulation of MYBL2 activity below levels predicted by classical haploinsufficiency underlies the clonal expansion of hematopoietic progenitors in a large fraction of human myeloid malignancies PMID: 23878725
    14. B-Myb plays a role in suppression of keratinocyte differentiation and maintenance of the undifferentiated proliferative phenotype by modulating the expression levels of cell cycle regulatory proteins, expressed in the S and G2/M phases of the cell cycle PMID: 24515894
    15. Results show that E7 interacts with the B-Myb, FoxM1 and LIN9 components of this activator complex, leading to cooperative transcriptional activation of mitotic genes in primary cells and E7 recruitment to the corresponding promoters. PMID: 24141769
    16. MYBL2 expression analysis could be useful to define subgroups of patients with poor prognosis. PMID: 24199710
    17. MALAT1-depleted cells display reduced expression of B-MYB (Mybl2), an oncogenic transcription factor involved in G2/M progression, due to altered binding of splicing factors on B-MYB pre-mRNA and aberrant alternative splicing PMID: 23555285
    18. Low MYBL2 expression is associated with haematopoietic neoplasia. PMID: 22910183
    19. A novel role for B-Myb in S-phase that appears to be independent of its sequence-specific DNA-binding activity and its ability to stimulate the expression of bona fide B-Myb target genes. PMID: 23032261
    20. Mybl2 upregulation induces fast growth and progression of premalignant and malignant liver, through cell cycle deregulation and activation of genes and pathways related to tumor progression. PMID: 21419759
    21. Owing to the role of B-Myb and E2F1 transcription factors in controlling cell-cycle progression of leukemic cells, the downregulation of these oncogenes by miR-34a suggests the usefulness of therapeutic approaches aimed to modulate the levels of miR-34a. PMID: 21367750
    22. study concludes that MYCN and B-MYB are engaged in a reciprocal regulatory loop whose pharmacological targeting could be beneficial to patients with the aggressive forms of cancer in which MYCN is amplified PMID: 21304178
    23. MYBL2 activation is crucial for human HCC progression. In particular, our data indicate that MYBL2-LIN9 complex integrity contributes to survival of DNA damaged p53(-/-) cells. PMID: 21480327
    24. B-MYB acts as a positive regulator of STRAP PMID: 21148321
    25. B-MYB represses p16(INK4alpha)by binding to a MYB-binding site within the promoter region. PMID: 20734103
    26. miR-29 and miR-30 regulate B-Myb expression by binding to its 3'UTR; these microRNAs play an important role in Rb-driven cellular senescence PMID: 21187425
    27. Data show that that ANCCA is crucial for proliferation and survival of triple-negative/basal-like cancer cells and that it controls the expression of B-Myb and histone methyltransferase EZH2. PMID: 20864510
    28. These data suggest that Mybl2 plays a subtle but key role in linking specific aspects of cell-cycle progression with generation of signals for differentiation. PMID: 20857481
    29. Study identified an overrepresentation of focal amplifications of known (FGFR3, CCND1, MYC, MDM2) and novel candidate genes (MYBL2, YWHAB and SDC4) in stage Ta bladder carcinoma. PMID: 19821490
    30. B-Myb transactivates the IGFBP-5 promoter PMID: 11973331
    31. ZPR9 plays an important role in modulation of the transactivation by B-MYB and cellular growth of neuroblastoma cells PMID: 12645566
    32. B-Myb repressor function is regulated by cyclin A phosphorylation and sequences within the C-terminal domain. PMID: 12673206
    33. it is evident that B-Myb protein may promote cell proliferation by a non-transcriptional mechanism that involves release of active cyclin/cyclin dependent kinase 2 from cyclin-dependent inhibitor 1C p57(KIP2) PMID: 12947099
    34. MRGX can repress or activate the B-myb promoter depending on the cell type studied, suggesting that there may be tissue-specific functions of this protein PMID: 14506250
    35. B-Myb has a role in regulation of c-Myc expression by cytosolic phospholipase A2 PMID: 14769798
    36. Human B-Myb reduces neointima formation after vascular injury in transgenic mice. PMID: 15256398
    37. regulated by temperature to activate genes required for cell survival. PMID: 15618219
    38. overexpressed during the S phase of the cell cycle compared with the G0/1 phase PMID: 16476973
    39. Chromosomal fragmentation and other aberrations, including shorter, thicker chromatids, end-to-end fusion, and loss of a chromatid, suggest that reduced B-Myb activity is also associated with structural chromosomal instability. PMID: 16551698
    40. Mip/LIN-9 is required for the expression of B-Myb, and both proteins collaborate in the control of the cell cycle progression via the regulation of S phase and cyclin A, cyclin B, and CDK1 PMID: 17098733
    41. human LIN-9, together with B-MYB, has a critical role in the activation of genes that are essential for progression into mitosis PMID: 17159899
    42. The repressor complex that Mip/LIN-9 forms with p107 takes functional precedence over the transcriptional activation linked to the Mip/LIN-9 and B-Myb interaction. PMID: 17563750
    43. The expression of stable, hypophosphorylated B-MYB in neuroblastoma may promote cell survival and induce aggressive tumour growth. PMID: 17588787
    44. Some B-MYB alleles might be associated with a reduced risk of developing neoplastic disease. PMID: 18026132
    45. MYBL2 gene expression was significantly higher in colorectal cancer patients than in healthy volunteers. PMID: 19016757
    46. Insight into the influence of B-Myb in human breast cancer, which is of potential clinical importance for determining disease risk and for guiding treatment. PMID: 19043454
    47. B-MYB fails to dissociate from LINC in p53 mutant cells, that this contributes to increased G(2)-M gene expression in response to DNA damage, and that B-MYB is required for recovery from the G(2) DNA damage checkpoint in p53-negative cells. PMID: 19383908

    顯示更多

    收起更多

  • 亞細(xì)胞定位:
    Nucleus.
  • 數(shù)據(jù)庫鏈接:

    HGNC: 7548

    OMIM: 601415

    KEGG: hsa:4605

    STRING: 9606.ENSP00000217026

    UniGene: Hs.179718



主站蜘蛛池模板: 香蕉视频在线精品视频| 人人狠狠综合久久88成人| 午夜三级a三级三点| 亚洲高清国产拍精品网络战| 无码国产玉足脚交极品网站| 午夜亚洲国产理论片二级港台二级| 中国大陆精品视频xxxx| 中文亚洲欧美日韩无线码 | 成人性生交片无码免费看| 极品粉嫩国产18尤物在线观看| 无码国模大尺度视频在线观看| 亚洲国产美女久久久久| 丰满肥臀大屁股熟妇激情视频| 亚洲字幕av一区二区三区四区| 精品无人区卡一卡二卡三乱码| 欧美精品九九久久久久久久久 | 久久国产精品_国产精品| 久久精品国产丝袜人妻| 精品一区二区ww| 日韩精品国产另类专区| 国产女人乱子对白av片| 国产高清在线精品一区| 丰满人妻被公侵犯高清版| 精品亚洲成a人片在线观看| 亚洲成a人片在线观看日本| 精品国产成人av在线| 99久久99久久久精品齐齐综合色圆| 国产精品美女久久久久久福利| 亚洲风影视传媒有限公司辽宁| 狠狠cao日日穞夜夜穞av| 丰满大爆乳波霸奶| 色avav色av爱avav亚洲色拍| 色婷婷五月综合色啪网| 97精品人人a片免费看| 色喜国模李晴超大尺度| 国产又色又爽又黄的视频在线观看| 好硬好湿好爽再深一点动态图视频| 无码人妻精品一区二区| 18禁勿入午夜网站入口| 日99久9在线 | 免费| 久久综合九色综合97欧美|